Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
Open Access
- 8 July 2008
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 99 (2), 230-238
- https://doi.org/10.1038/sj.bjc.6604462
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008
- Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationPopulation Health Metrics, 2007
- The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource settingBritish Journal of Cancer, 2007
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Effectiveness, safety and acceptability of ‘see and treat’ with cryotherapy by nurses in a cervical screening study in IndiaBritish Journal of Cancer, 2007
- A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast IndiaInternational Journal of Gynecologic Cancer, 2007
- Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in IndiaInternational Journal of Cancer, 2004
- Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern IndiaInternational Journal of Gynecologic Cancer, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Estimating CE Ratios under Second-order UncertaintyMedical Decision Making, 1997